ES2123635T3 - Nuevo inhibidor de la proteasa humana de tipo kunitz y sus variantes. - Google Patents

Nuevo inhibidor de la proteasa humana de tipo kunitz y sus variantes.

Info

Publication number
ES2123635T3
ES2123635T3 ES93902107T ES93902107T ES2123635T3 ES 2123635 T3 ES2123635 T3 ES 2123635T3 ES 93902107 T ES93902107 T ES 93902107T ES 93902107 T ES93902107 T ES 93902107T ES 2123635 T3 ES2123635 T3 ES 2123635T3
Authority
ES
Spain
Prior art keywords
phe
cys
gly
glu
protease inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902107T
Other languages
English (en)
Inventor
Fanny Norris
Kjeld Norris
Rn S Ren Erik Bj
Lars Christian Petersen
Ole Hvilsted Olsen
Donald Cameron Foster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2123635T3 publication Critical patent/ES2123635T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UNA INHIBIDOR DE PROTEASA DE TIPO KUNITZ HUMANO QUE COMPRENDE LA SIGUIENTE SECUENCIA AMINOACIDA LEU PRO ASN CYSALA PHE PRO MET GLU LYS PRO CYS GLN THRM TYR MET THR ARG TRP PHE PHE ASN PHE THR GLY GLU CYS GLU LEU PHE ALA TYR GLY GLY CYS GLY GLY ASN SER ASN ASN PHE LEU ARG LYS GLU LYS CYS GLU LYS PHE CYS PHE THR (SEQ ID NO 1) O UNA VARIANTE DE ESTA CON PROPIEDADES DE INHIBIDOR DE PROTEASA.
ES93902107T 1992-01-07 1993-01-07 Nuevo inhibidor de la proteasa humana de tipo kunitz y sus variantes. Expired - Lifetime ES2123635T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9200003 1992-01-07

Publications (1)

Publication Number Publication Date
ES2123635T3 true ES2123635T3 (es) 1999-01-16

Family

ID=8153772

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902107T Expired - Lifetime ES2123635T3 (es) 1992-01-07 1993-01-07 Nuevo inhibidor de la proteasa humana de tipo kunitz y sus variantes.

Country Status (17)

Country Link
US (1) US5618696A (es)
EP (1) EP0621873B1 (es)
JP (1) JP3345420B2 (es)
KR (1) KR940703860A (es)
AT (1) ATE171712T1 (es)
AU (1) AU670059B2 (es)
CA (1) CA2127247A1 (es)
CZ (1) CZ164894A3 (es)
DE (1) DE69321342T2 (es)
ES (1) ES2123635T3 (es)
FI (1) FI943235A (es)
HU (1) HUT70291A (es)
IL (1) IL104314A0 (es)
NO (1) NO942553L (es)
NZ (1) NZ246571A (es)
WO (1) WO1993014123A1 (es)
ZA (1) ZA9394B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134087A1 (en) * 1988-09-02 2006-06-22 Dyax Corp. ITI-D1 Kunitz domain mutants as hNE inhibitors
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
US6242414B1 (en) 1995-06-07 2001-06-05 Chiron Corporation Regulation of cytokine synthesis and release
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
ATE528014T1 (de) 2002-06-07 2011-10-15 Dyax Corp Polypeptid mit modifizierten kunitz domains
DE602004031589D1 (de) * 2003-01-07 2011-04-14 Dyax Corp Kunitz-domäne-bibliothek
MX2007000473A (es) * 2004-07-13 2007-03-29 Bayer Pharmaceuticals Corp Variantes mejoradas de la aprotinina.
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
LT1981519T (lt) 2005-12-29 2018-04-25 Dyax Corp. Proteazės slopinimas
AU2008289005A1 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
CN101952309A (zh) * 2007-12-21 2011-01-19 Ifxa有限公司 蛋白酶抑制剂
KR102165021B1 (ko) 2008-12-19 2020-10-14 박스알타 인코퍼레이티드 Tfpi 억제제 및 사용 방법
WO2010080833A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
HUE057244T2 (hu) 2010-01-06 2022-04-28 Takeda Pharmaceuticals Co Plazma kallikreint kötõ fehérjék
JP5730983B2 (ja) 2010-03-19 2015-06-10 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉ阻害剤および使用方法
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
SI2827883T1 (sl) 2012-03-21 2019-08-30 Baxalta GmbH Inhibitorji TFPI in postopki uporabe
JP6719384B2 (ja) 2014-03-27 2020-07-15 ダイアックス コーポレーション 糖尿病黄斑浮腫の治療のための組成物および方法
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP3468605A4 (en) * 2016-06-08 2020-01-08 President and Fellows of Harvard College MODIFIED VIRAL VECTOR REDUCING THE INDUCTION OF INFLAMMATORY AND IMMUNE RESPONSES
US11981911B2 (en) 2017-11-08 2024-05-14 President And Fellows Of Harvard College Compositions and methods for inhibiting viral vector-induced inflammatory responses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
DE3724570A1 (de) * 1987-06-27 1989-01-05 Bayer Ag Human-aprotinin, dessen lys-rest in position 15 gegen einen anderen protogenen aminosaeurerest ausgetauscht ist
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
JPH07102137B2 (ja) * 1988-07-19 1995-11-08 塩野義製薬株式会社 修飾ヒトｐｓｔｉ

Also Published As

Publication number Publication date
CZ164894A3 (en) 1994-12-15
NZ246571A (en) 1996-09-25
NO942553L (no) 1994-09-07
US5618696A (en) 1997-04-08
AU670059B2 (en) 1996-07-04
KR940703860A (ko) 1994-12-12
FI943235A0 (fi) 1994-07-06
FI943235A (fi) 1994-07-06
ZA9394B (en) 1993-08-10
EP0621873B1 (en) 1998-09-30
AU3346193A (en) 1993-08-03
NO942553D0 (no) 1994-07-06
CA2127247A1 (en) 1993-07-22
WO1993014123A1 (en) 1993-07-22
JP3345420B2 (ja) 2002-11-18
JPH07504652A (ja) 1995-05-25
HUT70291A (en) 1995-09-28
DE69321342D1 (de) 1998-11-05
EP0621873A1 (en) 1994-11-02
ATE171712T1 (de) 1998-10-15
DE69321342T2 (de) 1999-04-01
HU9401989D0 (en) 1994-09-28
IL104314A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
ES2123635T3 (es) Nuevo inhibidor de la proteasa humana de tipo kunitz y sus variantes.
HK1119955A1 (en) Modified kunitz domain polypeptide
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69128664T2 (de) CNP-Gen und Vorläuferprotein aus Schwein
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
DE3486154D1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
HUP9702500A2 (hu) Elhízás elleni proteinek
EP1225184A4 (en) HUMAN ANTITHROMBIN VARIANTS
WO1999057262A3 (de) An metallionen bindendes peptid
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos
AR009805A1 (es) Peptidos que contienen cisteina
DE60326726D1 (de) Peptide mit affinität für ein phospholipid und deren verwendung
CO4340568A1 (es) Familia de peptidos con 51 aminoacidos en longitud, secuen- cias de definicion, la planta transgenica comprendida, el vector de expresion recombinante y el metodo para su pro- duccion.
ECSP972344A (es) Proteinas antiobesidad

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19940525

FG2A Definitive protection

Ref document number: 621873

Country of ref document: ES